TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer

Elissa W. P. Wong,Merve Sahin,Rui Yang,UkJin Lee,Yingqian A. Zhan,Rohan Misra,Fanny Tomas,Nawaf Alomran,Alexander Polyzos,Cindy J. Lee,Tuan Trieu,Alexander M. Fundichely,Thomas Wiesner,Andrew Rosowicz,Shuyuan Cheng,Christina Liu Liu,Morgan Lallo,Taha Merghoub,Pierre-Jacques Hamard,Richard Koche,Ekta Khurana,Effie Apostolou,Deyou Zheng,Yu Chen,Christina S. Leslie,Ping Chi

DOI: https://doi.org/10.1101/2024.05.31.596845

2024-06-06

Abstract:Transposable elements (TEs) are abundant in the human genome, and they provide the sources for genetic and functional diversity. The regulation of TEs expression and their functional consequences in physiological conditions and cancer development remain to be fully elucidated. Previous studies suggested TEs are repressed by DNA methylation and chromatin modifications. The effect of 3D chromatin topology on TE regulation remains elusive. Here, by integrating transcriptome and 3D genome architecture studies, we showed that haploinsufficient loss of NIPBL selectively activates alternative promoters at the long terminal repeats (LTRs) of the TE subclasses. This activation occurs through the reorganization of topologically associating domain (TAD) hierarchical structures and recruitment of proximal enhancers. These observations indicate that TAD hierarchy restricts transcriptional activation of LTRs that already possess open chromatin features. In cancer, perturbation of the hierarchical chromatin topology can lead to co-option of LTRs as functional alternative promoters in a context-dependent manner and drive aberrant transcriptional activation of novel oncogenes and other divergent transcripts. These data uncovered a new layer of regulatory mechanism of TE expression beyond DNA and chromatin modification in human genome. They also posit the TAD hierarchy dysregulation as a novel mechanism for alternative promoter-mediated oncogene activation and transcriptional diversity in cancer, which may be exploited therapeutically.

Cancer Biology

What problem does this paper attempt to address?

The main issue this paper attempts to address is how the hierarchical structure of TADs (Topologically Associating Domains) restricts the activation of LTRs (Long Terminal Repeats), and how the disruption of TAD hierarchy in cancer promotes the co-option of LTRs, leading to aberrant transcriptional activation.

Specifically, researchers integrated transcriptomics and 3D genome architecture studies to discover that partial loss of NIPBL (a key protein involved in the establishment and maintenance of TADs) results in a reduction of TAD hierarchy and triggers global alternative promoter activation. These alternative promoters mainly originate from LTR elements that already exhibit open chromatin characteristics, particularly those located within nested TAD hierarchies. Further studies indicate that the reorganization of TAD hierarchy and the recruitment and redirection of nearby enhancers promote the activation of LTR alternative promoters. These findings reveal that in cancer, the disruption of TAD hierarchy can lead to the co-option of LTRs, thereby causing aberrant transcriptional activation of new oncogenes and other divergent transcripts.

In summary, this paper aims to elucidate the role of TAD hierarchy in regulating LTR expression and explore its potential mechanisms in cancer.